Latest news
Loading news…
XOMA is a biotechnology company focused on the development of innovative therapeutics for the treatment of diseases.
XOMA Royalty on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
XOMA Royalty was acquired by Ligand Pharmaceuticals in 2026.
Last Funding
Acquisitions
0
Monthly Visits
Contacts
0
Ticker
XOMA
NASDAQ
About XOMA Royalty
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- XOMA
- Exchange
- NASDAQ
- IPO date
- Jan 1, 1991
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Founded
- 1981
- Operating status
- Active
- Company type
- public
- Org types
- company
- HQ
- Berkeley, United States
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about XOMA Royalty
People who checked this page also checked these
Browse the full Acquirezy directory.